Genetic Inactivation of Sclerostin in a Mouse Model of Osteogenesis Imperfecta

被引：0
|
作者：
Boraschi-Diaz, Iris [1 ]
Tauer, Josephine T. [1 ]
Rauch, Frank [1 ]
机构：
[1] Shriners Hosp Children Canada, Montreal, PQ, Canada
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-858
引用
收藏
页码：366 / 366
页数：1
相关论文
共 50 条
  • [21] Anti-sclerostin antibodies and Intermittent PTH increase bone mass and strength in a mouse model of Type VI Osteogenesis Imperfecta
    Gerbaix, Maude
    Thouverey, Cyril
    Badoub, Isabelle
    Viallon, Solene
    Roche, Bernard
    Tomlinson, Ryan
    Crawford, Susan
    Helene, Lafage Proust Marie
    Serge, Ferrari
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 96 - 96
  • [22] Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength
    B. P. Sinder
    L. E. White
    J. D. Salemi
    M. S. Ominsky
    M. S. Caird
    J. C. Marini
    K. M. Kozloff
    Osteoporosis International, 2014, 25 : 2097 - 2107
  • [23] Tissue level material composition and mechanical properties in Brtl/plus mouse model of Osteogenesis Imperfecta after sclerostin antibody treatment
    Lloyd, William R.
    Sinder, Benjamin P.
    Salemi, Joseph
    Ominsky, Michael S.
    Marini, Joan C.
    Caird, Michelle S.
    Morris, Michael D.
    Kozloff, Kenneth M.
    PHOTONIC THERAPEUTICS AND DIAGNOSTICS XI, 2015, 9303
  • [24] Gene expression profiling of sclerostin antibody-induced therapeutic response in growing Brtl/ plus mouse model of osteogenesis imperfecta
    Sung, Hsiao Hsin
    Surowiec, Rachel
    Falzon, Rebecca
    Battle, Lauren
    Stephan, Chris
    Caird, Michelle S.
    Kozloff, Kenneth M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 124 - 124
  • [25] Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength
    Sinder, B. P.
    White, L. E.
    Salemi, J. D.
    Ominsky, M. S.
    Caird, M. S.
    Marini, J. C.
    Kozloff, K. M.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (08) : 2097 - 2107
  • [26] Osteogenesis Imperfecta: Genetic evaluation
    Castro-Feijoo, Lidia
    de la Torre, Marina
    Cabanas, Paloma
    Pino, Jesus
    Pombo, Manuel
    Barreiro, Jesus
    Loidi, Lourdes
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 388 - 389
  • [27] TRANSGENIC MOUSE MODEL OF THE MILD DOMINANT FORM OF OSTEOGENESIS IMPERFECTA
    BONADIO, J
    SAUNDERS, TL
    TSAI, E
    GOLDSTEIN, SA
    MORRISWIMAN, J
    BRINKLEY, L
    DOLAN, DF
    ALTSCHULER, RA
    HAWKINS, JE
    BATEMAN, JF
    MASCARA, T
    JAENISCH, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 7145 - 7149
  • [28] Sclerostin antibody reduces long bone fractures in the oim/oim model of, Check for osteogenesis imperfecta
    Cardinal, Mickael
    Tys, Janne
    Roels, Thomas
    Lafont, Sebastien
    Ominsky, Michael S.
    Devogelaer, Jean-Pierre
    Chappard, Daniel
    Mabilleau, Guillaume
    Ammann, Patrick
    Nyssen-Behets, Catherine
    Manicourt, Daniel H.
    BONE, 2019, 124 : 137 - 147
  • [29] Oesophageal morphometry and residual strain in a mouse model of osteogenesis imperfecta
    Gregersen, H
    Weis, SM
    McCulloch, AD
    NEUROGASTROENTEROLOGY AND MOTILITY, 2001, 13 (05): : 457 - 464
  • [30] Changes in activity as a measure of pain in a mouse model of Osteogenesis Imperfecta
    Lee, Stephanie
    Villa, Francesco
    Jacobsen, Christina
    Warman, Matthew
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 220 - 220
12345